“Kisspeptin-10”的搜索结果，显示 31-40 项，共有 6065 项

1. 血液科- 临床试验- 妙佑医疗国际

   A selected subset of participants (10 survivors and 10 caregivers) will be chosen to undergo semi-structured open ended interviewing to obtain a qualitative ...

2. 神经科- 临床试验- 妙佑医疗国际

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a neutrophil ...

3. 脑肿瘤项目- 临床试验- 妙佑医疗国际

   ... (10) advanced, unresectable multiple myeloma. Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with ...

4. 神经科- 临床试验- 妙佑医疗国际

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a neutrophil ...

5. 脑肿瘤项目- 临床试验- 妙佑医疗国际

   ... (10) advanced, unresectable multiple myeloma. Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with ...

6. 神经科- 临床试验- 妙佑医疗国际

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a neutrophil ...

7. 神经科- 临床试验- 妙佑医疗国际

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a neutrophil ...

8. 神经科- 临床试验- 妙佑医疗国际

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a neutrophil ...

9. 外科 - 临床试验- 妙佑医疗国际

   Go to page 1010 · Go to page 1111 · Go to page 1212 · NextNext Page. 以下为当前的临床试验。 121 研究外科（仅限开放性研究）. 按位置、状态和其他条件筛选该研究列表 ...

10. 血液科- 临床试验- 妙佑医疗国际

    A selected subset of participants (10 survivors and 10 caregivers) will be ... (10) advanced, unresectable multiple myeloma. Also eligible are (11) up ...